ZJU-6, a novel derivative of Erianin, shows potent anti-tubulin polymerisation and anti-angiogenic activities
Authors:
- 14 October 2011
- journal article
- Published by Springer Nature in Investigational New Drugs
- Vol. 30 (5) , 1899-1907
Abstract
ZJU-6 was designed to enhance anti-angiogenesis and anti-tumour activity of its parent compound Erianin, a clinic anti-tumour agent. This study investigated the detailed biological mechanism of ZJU-6 in comparison with that of Erianin. Both ZJU-6 and Erianin substantially reduced cell viability and induced apoptosis in human cancer cell lines. Profound G2/M cell arrest was observed 24 h after treatment of MCF-7 cells with ZJU-6 (≥ 2.5 μM) or Erianin (≥ 0.1 μM); being consistent with mitotic collapse. 0.5 μM of Erianin or ZJU-6 failed to stabilise tubulin. Pre-G1 MCF-7 cell accumulating 24 h post treatment indicated apoptosis. Caspase-3 activity, PARP cleavage and Annexin V + ve /PI -ve populations correlate the apoptotic destiny of cells exposed to either ZJU-6 or Erianin. Furthermore ZJU-6 showed potent anti-angiogenetic property and demonstrated radical scavenging capacity. Due to its potent anti-proliferative, pro-apoptotic and anti-angiogenic activities ZJU-6 is an attractive chemotherapeutic agent to be developed.Keywords
This publication has 20 references indexed in Scilit:
- In vitro antitumor mechanism of a novel cyclin-dependent kinase inhibitor CDKI-83Investigational New Drugs, 2011
- Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell deathBlood, 2005
- Erianin induces a JNK/SAPK-dependent metabolic inhibition in human umbilical vein endothelial cells.2004
- A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrolCarcinogenesis, 2001
- Hydrogen peroxide stimulates macrophage vascular endothelial growth factor releaseAmerican Journal of Physiology-Heart and Circulatory Physiology, 2001
- The Hallmarks of CancerCell, 2000
- Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues.1999
- In vivo radioprotection and effects on blood pressure of the stable free radical nitroxidesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.Journal of Clinical Investigation, 1996
- A simple procedure for the long-term cultivation of chicken embryosDevelopmental Biology, 1974